Incidence and predictors of cardiac markers elevation after coronary intervention

This study evaluated the incidence and predictors of CK-MB and troponin elevation after successful coronary intervention. CK-MB and troponin elevation after coronary intervention correlate with late cardiac events and survival. [1, 2, 19, 24] We investigated the incidence and predictors of CK-MB and troponin elevation in patients who underwent percutaneous coronary intervention in Rajaie Cardiovascular, Medical and Research Center. CK-MB and troponin elevation was detectable in 203 [70%] patients. Predictors of cardiac enzyme elevation were hyperlipidemia, functional class, and smoking. There were no in-hospital adverse events in the CK-MB and troponin elevation group. Cardiac enzyme elevation after coronary intervention was detected in 70% of all our patients and was more common in diffuse atherosclerosis hyperlipidemia, smoking, and high functional class. Enzyme elevation was observed even in the absence of discernible procedural complications, and early discharge of patients with CK-MB and troponin elevation is safe. Midterm survival of patients with CK-MB and or troponin elevation was similar to those with normal enzymes

Thromboendarterectomy in chronic pulmonary thromboembolism

Chronic pulmonary thromboembolic disease in entrapment of thrombus in pulmonary arteries from a single episode or repeated embolic episodes that subsequently organize, or thrombi that develop inside the pulmonary arteries into firm, fibrous tissue that becomes incorporated into the vessel wall. We operated 7 patients with stage chronic pulmonary thromboembolism over a two year period at our center. Four patients had good function class after operation on follow up at 6 to 12 months and we administered warafarin prophylaxis [with international normalized ratio, INR, of 3] for them. Three patients died in hospital postoperatively. We used extracorporeal membrane oxygenation [ECMO] for one of them but it failed on the third postoperative day